Onderneming Chengdu Easton Biopharmaceuticals Co., Ltd.
Aandelen
688513
CNE100004397
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
56,68 CNY | +1,76% | +2,55% | -11,13% |
Vakgebied
Aantal werknemers: 1 400
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Chemical Preparations
78,8
%
| 1 019 | 87,1 % | 881 | 78,8 % | -13,61% |
Technical Services and Transfer
9,8
%
| 44 | 3,8 % | 110 | 9,8 % | +150,21% |
Application Programming Interface
8,4
%
| 82 | 7,0 % | 94 | 8,4 % | +14,64% |
Contract Manufacturing Organization/Contract Development and Manufacturing Organization
2,8
%
| 24 | 2,1 % | 31 | 2,8 % | +26,79% |
Other
0,1
%
| 1 | 0,1 % | 1 | 0,1 % | +124,89% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
98,8
%
| 1 160 | 99,1 % | 1 103 | 98,8 % | -4,89% |
Overseas
1,2
%
| 10 | 0,9 % | 14 | 1,2 % | +31,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ming Xu Yuan
CEO | Chief Executive Officer | 53 | 01-01-09 |
Ying Wang
FOU | Founder | 58 | 01-06-09 |
Jia Yu Zhu
CHM | Chairman | 44 | 01-01-09 |
Chen Hong
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-07-19 |
Zeng Gui Chen
BRD | Director/Board Member | 53 | 01-01-09 |
Peng Fei Deng
BRD | Director/Board Member | 38 | 01-01-12 |
Da Ming Zhang
BRD | Director/Board Member | 52 | 01-01-09 |
Shu Yun Li
IRC | Investor Relations Contact | 39 | 01-10-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hong Wu Geng
BRD | Director/Board Member | 56 | 23-12-21 |
Ying Wang
FOU | Founder | 58 | 01-06-09 |
Da Ming Zhang
BRD | Director/Board Member | 52 | 01-01-09 |
Ming Xu Yuan
CEO | Chief Executive Officer | 53 | 01-01-09 |
Jin Li
BRD | Director/Board Member | 59 | 27-12-18 |
Jia Yu Zhu
CHM | Chairman | 44 | 01-01-09 |
Peng Fei Deng
BRD | Director/Board Member | 38 | 01-01-12 |
Fang Fang
BRD | Director/Board Member | 42 | 13-10-20 |
Zeng Gui Chen
BRD | Director/Board Member | 53 | 01-01-09 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 120 090 000 | 54 530 000 ( 45,41 %) | 1 091 092 ( 0,9086 %) | 45,41 % |
Bedrijfsgegevens
Chengdu Easton Biopharmaceuticals Co., Ltd.
8 Ankang Road Shuangliu District
610219, Chengdu
+
http://www.eastonpharma.cnSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,13% | 915 mln. | |
+48,53% | 779 mld. | |
+40,67% | 631 mld. | |
-6,37% | 354 mld. | |
+20,93% | 333 mld. | |
+8,21% | 301 mld. | |
+16,75% | 249 mld. | |
-1,19% | 216 mld. | |
+10,85% | 214 mld. | |
+4,40% | 163 mld. |
- Beurs
- Aandelen
- Koers 688513
- Onderneming Chengdu Easton Biopharmaceuticals Co., Ltd.